EGF-associated pathways and angiopoietin 2 have been used as a point of differentiation between grade IV astrocytoma, i.e., glioblastoma multiform from lower-grade astrocytoma [571,594,595,596]. The gene discussed is EGF; the disease is astrocytoma (excluding glioblastoma).